Loss of CYLD on Chromosome 16q Impairs Homologous Recombination and Genomic Stability Through TIRR Degradation
Advanced Science · 2026-11 · 13 (62)
DOI: 10.1002/advs.77298 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 21.08.2026. Verfasst von Mingming Lu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China. Hauptthemen laut MEDLINE: Deubiquitinating Enzyme CYLD, Genomic Instability, Chromosomes, Human, Pair 16, Homologous Recombination. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Clinical Research Special Fund of the Wu Jieping Medical Foundation.
Abstract (Originalsprache)
Loss of chromosome 16q is a recurrent genomic alteration in bladder and prostate cancers and is associated with poor clinical outcomes. However, the mechanisms by which 16q loss contributes to tumor progression remain poorly understood. Here, we identify the deubiquitinase CYLD as a major contributor to genomic instability associated with chromosome 16q deletion. Mechanistically, CYLD stabilizes the 53BP1 regulator TIRR by removing K48‐linked polyubiquitin chains, thereby preventing excessive accumulation of 53BP1 at sites of DNA damage and maintaining efficient homologous recombination repair. Loss of CYLD disrupts this regulation, shifting DNA double‐strand break repair toward 53BP1‐dependent non‐homologous end joining, leading to homologous recombination deficiency. Consequently, CYLD‐deficient tumor cells exhibit increased sensitivity to PARP inhibitors. Together, these findings establish CYLD as a critical regulator of DNA double‐strand break repair pathway choice and suggest that CYLD loss, or chromosome 16q deletion, may serve as a biomarker of genomic instability and a predictor of response to PARP inhibitor therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.
- Department of Urology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
- Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.
- Department of Surgical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.
ORCID-Profile: Yuzeshi Lei, Tianjie Liu, Bin Wang, Lei Li
Förderung
- National Natural Science Foundation of China
- Clinical Research Special Fund of the Wu Jieping Medical Foundation
Zitieren
APA
Lu, M., Kang, J., Ye, Q., Wang, Z., Li, L., Lei, Y., Ye, L., Liu, T., Wang, B., Liu, T., Xu, S., Wang, K., Zhang, Y., Ma, J., & Li, L. (2026). Loss of CYLD on Chromosome 16q Impairs Homologous Recombination and Genomic Stability Through TIRR Degradation. Advanced Science, 13(62). https://doi.org/10.1002/advs.77298
Vancouver
Lu M, Kang J, Ye Q, Wang Z, Li L, Lei Y, et al. Loss of CYLD on Chromosome 16q Impairs Homologous Recombination and Genomic Stability Through TIRR Degradation. Advanced Science. 2026;13(62). doi:10.1002/advs.77298
BibTeX
@article{Lu2026,
author = {Lu, Mingming and Kang, Jialu and Ye, Qi and Wang, Zixi and Li, Lei and Lei, Yuzeshi and Ye, Leihong and Liu, Tianjie and Wang, Bin and Liu, Tao and Xu, Shan and Wang, Ke and Zhang, Yong and Ma, Jian and Li, Lei},
title = {Loss of CYLD on Chromosome 16q Impairs Homologous Recombination and Genomic Stability Through TIRR Degradation},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {62},
doi = {10.1002/advs.77298}
}
EUVIMED